Back

Inhibition of alphaV integrins with cilengitide downregulates in vitro pro-fibrotic events in aortic smooth muscle cells and limits in vivo thoracic aortic aneurysm progression

12 April 2024 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session 1 Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Gianluca Lorenzo Perrucci

Monzino Cardiology Centre, Milan (Italy)

68 More presentations in this session

Presentation thumbnail
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes
Assistant Professor J. Buikema (Amsterdam, NL)
Abstract
Presentation thumbnail
Role of NLRP3 inflammasome in cardiac damage in the setting of an acute cardiorenal syndrome
Ms L. Gonzalez-Lafuente (Madrid, ES)
Abstract
Presentation thumbnail
Altered firing activity of intracardiac neurons isolated from mice carrying the Scn5a-1798insD mutation
Doctor S. Casini (Amsterdam, NL)
Abstract
Presentation thumbnail
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
Mr J. Wang (Amsterdam, NL)
Abstract
Presentation thumbnail
Cardioprotective effects of Empagliflozin in cardiac volume overload-induced by aortocaval fistula in rats
Doctor M. Sykora (Bratislava, SK)
Abstract

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

12 April 2024 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources